Mosaic ImmunoEngineering (Mosaic ImmunoEngineering) EV-to-EBIT : -6.01 (As of May. 02, 2024)

Mosaic ImmunoEngineering EV-to-EBIT Chart

Mosaic ImmunoEngineering Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					0.45	-0.03	-2.24	-3.67	-6.01

Mosaic ImmunoEngineering Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-3.67	-3.90	-8.64	-4.48	-6.01

Competitive Comparison of Mosaic ImmunoEngineering's EV-to-EBIT

For the Biotechnology subindustry, Mosaic ImmunoEngineering's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mosaic ImmunoEngineering's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mosaic ImmunoEngineering's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mosaic ImmunoEngineering's EV-to-EBIT falls into.

Mosaic ImmunoEngineering EV-to-EBIT Calculation

Mosaic ImmunoEngineering's EV-to-EBIT for today is calculated as:

Mosaic ImmunoEngineering's current Enterprise Value is $5.51 Mil.
Mosaic ImmunoEngineering's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mosaic ImmunoEngineering  (OTCPK:CPMV) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mosaic ImmunoEngineering's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Mosaic ImmunoEngineering's Enterprise Value for the quarter that ended in Dec. 2023 was $5.51 Mil.
Mosaic ImmunoEngineering's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mosaic ImmunoEngineering EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mosaic ImmunoEngineering's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mosaic ImmunoEngineering (Mosaic ImmunoEngineering) Business Description